Although controversy remains as to whether plasma NfL levels are elevated in patients with PD compared with those in HCs [14, 34–36], the NfL value has been significantly associated with both motor severity and cognitive decline in PD [37–39], suggesting its usefulness as a disease progression marker in PD. This evidence concerns the gene NEFL and Parkinson disease.